{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:19:28Z","timestamp":1773299968226,"version":"3.50.1"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,4,7]]},"DOI":"10.1093\/eurheartj\/eht384","type":"journal-article","created":{"date-parts":[[2013,9,26]],"date-time":"2013-09-26T23:50:52Z","timestamp":1380239452000},"page":"895-903","source":"Crossref","is-referenced-by-count":35,"title":["Efficacy of the long-acting nitro vasodilator pentaerithrityl tetranitrate in patients with chronic stable angina pectoris receiving anti-anginal background therapy with beta-blockers: a 12-week, randomized, double-blind, placebo-controlled trial"],"prefix":"10.1093","volume":"35","author":[{"given":"Thomas","family":"M\u00fcnzel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Meinertz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Tebbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinrich Theodor","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Stalleicken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manfred","family":"Wargenau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"Gori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Klingmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2013,9,26]]},"reference":[{"key":"key\n\t\t\t\t20170516121958_EHT384C1","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/eurheartj\/ehl001","article-title":"Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology","volume":"27","author":"Fox","year":"2006","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170516121958_EHT384C2","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1161\/CIRCULATIONAHA.110.981407","article-title":"Nitrate therapy: new aspects concerning molecular action and tolerance","volume":"123","author":"Munzel","year":"2011","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170516121958_EHT384C3","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1161\/01.CIR.76.3.577","article-title":"Incidence of early tolerance to hemodynamic effects of continuous infusion of nitroglycerin in patients with coronary artery disease and heart failure","volume":"76","author":"Elkayam","year":"1987","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170516121958_EHT384C4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00045391-199406000-00015","article-title":"Current status of isosorbide-5-mononitrate therapy in chronic stable angina pectoris","volume":"1","author":"Nyberg","year":"1994","journal-title":"Am J Ther"},{"key":"key\n\t\t\t\t20170516121958_EHT384C5","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1161\/01.CIR.84.5.2040","article-title":"Randomized study to evaluate the relation between oral isosorbide dinitrate dosing interval and the development of early tolerance to its effect on left ventricular filling pressure in patients with chronic heart failure","volume":"84","author":"Elkayam","year":"1991","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170516121958_EHT384C6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/01.fjc.0000162771.00174.a8","article-title":"Effects of the long-term administration of nicorandil on vascular endothelial function and the progression of arteriosclerosis","volume":"46","author":"Sekiya","year":"2005","journal-title":"J Cardiovasc Pharmacol"},{"key":"key\n\t\t\t\t20170516121958_EHT384C7","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.jacc.2006.10.074","article-title":"Once daily therapy with isosorbide-5-mononitrate causes endothelial dysfunction in humans: evidence of a free-radical-mediated mechanism","volume":"49","author":"Thomas","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170516121958_EHT384C8","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1161\/hc3501.095358","article-title":"Folic acid prevents nitroglycerin-induced nitric oxide synthase dysfunction and nitrate tolerance: a human in vivo study","volume":"104","author":"Gori","year":"2001","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170516121958_EHT384C9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00392-009-0096-z","article-title":"Effects of pentaerythritol tetranitrate on endothelial function in coronary artery disease: results of the PENTA study","volume":"99","author":"Schnorbus","year":"2011","journal-title":"Clin Res Cardiol"},{"key":"key\n\t\t\t\t20170516121958_EHT384C10","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.2337\/db10-1395","article-title":"Vascular dysfunction in experimental diabetes is improved by pentaerithrityl tetranitrate but not isosorbide-5-mononitrate therapy","volume":"60","author":"Schuhmacher","year":"2011","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t20170516121958_EHT384C11","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1089\/ars.2010.3503","article-title":"Organic nitrates differentially modulate circulating endothelial progenitor cells and endothelial function in patients with symptomatic coronary artery disease","volume":"15","author":"Thum","year":"2012","journal-title":"Antioxid Redox Signal"},{"key":"key\n\t\t\t\t20170516121958_EHT384C12","doi-asserted-by":"crossref","first-page":"H340","DOI":"10.1152\/ajpheart.01324.2008","article-title":"Tolerance to nitroglycerin-induced preconditioning of the endothelium: a human in vivo study","volume":"298","author":"Gori","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"key\n\t\t\t\t20170516121958_EHT384C13","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1161\/ATVBAHA.107.149278","article-title":"Pentaerythrityl tetranitrate and nitroglycerin, but not isosorbide mononitrate, prevent endothelial dysfunction induced by ischemia and reperfusion","volume":"27","author":"Dragoni","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t20170516121958_EHT384C14","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0002-9149(92)90680-W","article-title":"Comparison of ischemic and physiologic responses during exercise tests in men using the standard and modified Bruce protocols","volume":"69","author":"McInnis","year":"1992","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20170516121958_EHT384C15","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0735-1097(02)02164-2","article-title":"ACC\/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines)","volume":"40","author":"Gibbons","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170516121958_EHT384C16","doi-asserted-by":"crossref","first-page":"735","DOI":"10.7326\/0003-4819-157-10-201211200-00011","article-title":"Management of stable ischemic heart disease: summary of a clinical practice guideline from the American College of Physicians\/American College of Cardiology Foundation\/American Heart Association\/American Association for Thoracic Surgery\/Preventive Cardiovascular Nurses Association\/Society of Thoracic Surgeons","volume":"157","author":"Qaseem","year":"2012","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20170516121958_EHT384C17"},{"key":"key\n\t\t\t\t20170516121958_EHT384C18","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/0735-1097(89)90216-7","article-title":"Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina","volume":"13","author":"DeMots","year":"1989","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170516121958_EHT384C19","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1161\/01.CIR.84.6.2336","article-title":"Counter-regulatory responses to continuous and intermittent therapy with nitroglycerin","volume":"84","author":"Parker","year":"1991","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170516121958_EHT384C20","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1161\/01.CIR.91.4.973","article-title":"Intermittent transdermal nitroglycerin therapy. Decreased anginal threshold during the nitrate-free interval","volume":"91","author":"Parker","year":"1995","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170516121958_EHT384C21","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1161\/01.CIR.91.5.1368","article-title":"Intermittent transdermal nitroglycerin therapy in angina pectoris. Clinically effective without tolerance or rebound. Minitran Efficacy Study Group","volume":"91","author":"Parker","year":"1995","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170516121958_EHT384C22","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0735-1097(97)00268-4","article-title":"Effects of intermittent transdermal nitroglycerin on occurrence of ischemia after patch removal: results of the Second Transdermal Intermittent Dosing Evaluation Study (TIDES-II)","volume":"30","author":"Pepine","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170516121958_EHT384C23","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/oxfordjournals.eurheartj.a059425","article-title":"Intermittent transdermal nitroglycerin monotherapy in stable exercise-induced angina: a comparison with a continuous schedule","volume":"10","author":"Ferratini","year":"1989","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170516121958_EHT384C24","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1161\/ATVBAHA.107.143909","article-title":"Heme oxygenase-1: a novel key player in the development of tolerance in response to organic nitrates","volume":"27","author":"Wenzel","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t20170516121958_EHT384C25","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0735-1097(01)01414-0","article-title":"Differential effects of pentaerythritol tetranitrate and nitroglycerin on the development of tolerance and evidence of lipid peroxidation: a human in vivo study","volume":"38","author":"Jurt","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170516121958_EHT384C26","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1378\/chest.80.2.142","article-title":"The prolonged effect of pentaerythritol tetranitrate on exercise capacity in stable effort angina pectoris","volume":"80","author":"Giles","year":"1981","journal-title":"Chest"},{"issue":"34 Suppl.","key":"key\n\t\t\t\t20170516121958_EHT384C27","first-page":"2487","article-title":"Antianginal effects of pentaerythritol tetranitrate","volume":"9","author":"Arce-Gomez","year":"1980","journal-title":"Nouv Presse Med"},{"key":"key\n\t\t\t\t20170516121958_EHT384C28","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/eurheartj\/ehn571","article-title":"Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial","volume":"30","author":"Tardif","year":"2009","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170516121958_EHT384C29","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.291.3.309","article-title":"Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial","volume":"291","author":"Chaitman","year":"2004","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170516121958_EHT384C30","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/oxfordjournals.eurheartj.a014699","article-title":"The Total Ischaemic Burden European Trial (TIBET). Effects of atenolol, nifedipine SR and their combination on the exercise test and the total ischaemic burden in 608 patients with stable angina. The TIBET Study Group","volume":"17","author":"Fox","year":"1996","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170516121958_EHT384C31","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0002-9149(97)00893-X","article-title":"Amlodipine versus diltiazem as additional antianginal treatment to atenolol. Centralised European Studies in Angina Research (CESAR) Investigators","volume":"81","author":"Knight","year":"1998","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20170516121958_EHT384C32","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/clc.4960231014","article-title":"Monotherapy with amlodipine or atenolol versus their combination in stable angina pectoris","volume":"23","author":"Pehrsson","year":"2000","journal-title":"Clin Cardiol"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/35\/14\/895\/17155368\/eht384.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T06:58:10Z","timestamp":1503471490000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-lookup\/doi\/10.1093\/eurheartj\/eht384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,26]]},"references-count":32,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2013,9,26]]},"published-print":{"date-parts":[[2014,4,7]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/eht384","relation":{},"ISSN":["1522-9645","0195-668X"],"issn-type":[{"value":"1522-9645","type":"electronic"},{"value":"0195-668X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9,26]]}}}